Retinal Biologics Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Retinal Biologics Market is expected to hold a value of about USD 34,891.44 Million by 2028 and is projected to register a CAGR of 11% from 2022 to 2028.

Retinal biologics are bioengineered molecules used to treat a variety of retinal disorders. These biologics are usually implanted into the eye to treat chronic retinal disease. Various types of retinal disorders predominate, most of which cause visual impairment. Age-related macular degeneration (AMD) is one of the leading causes of blindness among people over the age of 50. Treatment of retinal disorders includes a variety of approaches through surgery and those with frequent use of drugs. The retina is a very sensitive and complex part of the human eye system, which acts as a receiver and processor of light and converts it into neural signals that are transmitted to the brain for visual operation. Retinal function and structure is affected by disorders related to the retina, such as diabetic retinopathy, age-related macular degeneration, infectious retinitis, macular edema, retinoblastoma, schizophrenia, retinal degeneration, and other disorders.

Market Segments

By Drug Class

• TNF-α Inhibitor
• VEGF-A Antagonist

By Indication

• Macular Degeneration
• Diabetic Retinopathy
• Uveitis

Key Players

• Regeneron Pharmaceuticals Inc. (US)
• Ocular Therapeutixc.(US)
• Hoffmann-La Roche Ltd (Basel, Switzerland)
• AbbVie Inc. (US)
• Johnson & Johnson Services, Inc. (US)
• Amgen Inc. (US)
• MeiraGTx Limited (US)

Scope of the Report

The research study analyzes the global Retinal Biologics industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Retinal Biologics Market Report

1. What was the Retinal Biologics Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Retinal Biologics Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Retinal Biologics Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.